Maia Hansen, SVP and Head of Operations and Supply Chain, and James Glover, SVP Commercial Manufacturing, will be participating in person at the 4th Allogeneic Cell Therapies Summit which takes place May 9-12 in Boston, Massachusetts.
Ms. Hansen will be giving a presentation titled “The Last Mile to the Patient in Allogeneic Cell Therapy” on Tuesday May 10th at 4:45 p.m. ET. The presentation will include information on the preparation and delivery of allogeneic cell therapies to patients. The presentation will also highlight emerging developments in logistics, equipment, and service providers.
Mr. Glover has been invited to speak in an expert-led panel discussion titled “Process Development for Scalable Manufacture” on Tuesday May 10th at 3:30 p.m. ET. In addition, Mr. Glover will be giving a presentation titled “Considerations for the Design of a Cost-Effective Commercial Manufacturing Facility” on Wednesday May 11th at 2:00 p.m. ET. The presentation will include information on planning for commercial manufacture of an allogeneic product and improving cost of goods.
Download the full agenda here: https://ter.li/officialagenda2022